CRLBF — Cresco Labs Inc.
—
OTC ·
Materials ·
Chemicals ·
CIK 1832928 ·
Last close
$0.47
Market Cap
$167.84M
52W High
$2.30
52W Low
$0.46
ADV30
581,410
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 172,782,000 | 79,486,000 | 10,662,000 | -12,441,000 | 1,253,057,000 | 41,169,000 | 1,000,850,000 |
| Jun 2026 | 173,341,000 | 86,947,000 | 13,361,000 | 16,796,000 | 1,263,320,000 | 32,872,000 | 999,970,000 |
| Mar 2026 | 151,325,000 | 75,449,000 | 11,173,000 | -13,072,000 | 1,198,859,000 | 32,345,000 | 954,648,000 |
| Dec 2025 | 161,553,000 | 83,321,000 | 17,755,000 | -87,588,000 | 1,197,300,000 | 57,902,000 | 944,798,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$43,390,000
Investing CF
$-43,038,000
Financing CF
$-85,974,000
CapEx
$-38,751,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.10
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,498,977,000
Inventory
$111,172,000
Receivables
$39,884,000
ST Investments
—
EBIT TTM
$-41,898,000
Pretax Income TTM
$-103,638,000
Interest Exp TTM
$61,740,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$651,132,032
EBITDA
$111,141,000
Free Cash Flow
$24,946,750
Enterprise Value
$729,322,752
Total Cash
$32,872,000
Total Debt
$592,017,984
Shares Out
355,588,670
Trailing EPS
$-0.28
Book Value
$0.96
ROE
-36.1%
ROA
3.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 655,847,000 | 76,944,000 | -135,408,000 | 1,197,300,000 | 944,798,000 | 340,449,000 | 72,890,000 |
| Dec 2024 | 724,343,000 | 109,282,000 | -74,438,000 | 1,355,355,000 | 967,179,000 | 474,854,000 | 132,480,000 |
| Dec 2023 | 770,885,000 | 62,880,000 | -175,522,000 | 1,358,467,000 | 930,400,000 | 505,692,000 | 58,564,000 |
| Dec 2022 | 842,681,000 | 56,932,000 | -212,047,000 | 1,583,692,000 | 996,009,000 | 627,039,000 | 18,741,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NAGE | Niagen Bioscience, Inc. | $161.56M | $2.04 | — |
| MDWD | MediWound Ltd. | $176.61M | $13.68 | — |
| BAK | BRASKEM SA | $153.57M | $0.89 | — |
| GLAS | Glass House Brands Inc. | $146.08M | $1.66 | — |
| LTBR | LIGHTBRIDGE Corp | $145.37M | $3.75 | — |
News headlines (Yahoo Finance, 1h cache)
Cresco Labs Inc (CRLBF) (Q3 2026) Earnings Call Highlights: Strong Cash Flow and Pennsylvania ...
2026-11-06 23:15 · Yahoo
Cresco Labs Inc. (CRLBF) Reports Q3 Loss, Misses Revenue Estimates
2026-11-06 12:55 · Yahoo
Cresco Labs Reports Third Quarter 2026 Financial Results
2026-11-06 11:30 · Yahoo
Aurora Cannabis Inc. (ACB) Q2 Earnings and Revenues Top Estimates
2026-11-05 13:35 · Yahoo
Cresco Labs Advances Innovation Pipeline with High Supply SLIPS and Wonder THC Drink Mixes
2026-11-05 11:30 · Yahoo
Perrigo (PRGO) Surpasses Q3 Earnings Estimates
2026-11-04 11:50 · Yahoo
Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders
2026-11-02 11:30 · Yahoo
Cresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical Cannabis
2026-10-23 10:30 · Yahoo
Cresco Labs to Report Third Quarter 2026 Financial Results on November 6, 2026
2026-10-15 10:30 · Yahoo
Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting
2026-10-09 21:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.